Clinical Trial Update: Ursodiol-Methotrexate for Primary Biliary Cirrhosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Ursodiol in combination with Methotrexate for primary biliary cholangitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• URSODIOL (ursodiol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Liver Cirrhosis, Biliary | Phase 3 | Status: COMPLETED